Company

STRATEC SE

Headquarters: Birkenfeld, Germany

Employees: 1,406

CEO: Mr. Marcus Wolfinger

Market Cap

€514.8 Million

EUR as of Jan. 1, 2024

US$568.6 Million

Market Cap History

STRATEC SE market capitalization over time

Evolution of STRATEC SE market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of STRATEC SE

Detailed Description

Stratec SE designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany and internationally. It operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.

Top 1-year algo backtest: +284.14%

$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

STRATEC SE has the following listings and related stock indices.


Stock: XETR: SBS wb_incandescent

Stock: FSX: SBS wb_incandescent

Details

Headquarters:

Gewerbestrasse 35-37

Birkenfeld, 75217

Germany

Phone: 49 7082 7916 0

Fax: 49 7082 7916 999